L. Foroni

712 total citations
28 papers, 528 citations indexed

About

L. Foroni is a scholar working on Geriatrics and Gerontology, Epidemiology and Infectious Diseases. According to data from OpenAlex, L. Foroni has authored 28 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Geriatrics and Gerontology, 11 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in L. Foroni's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Antifungal resistance and susceptibility (8 papers) and Pharmacy and Medical Practices (6 papers). L. Foroni is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Antifungal resistance and susceptibility (8 papers) and Pharmacy and Medical Practices (6 papers). L. Foroni collaborates with scholars based in France, United States and United Kingdom. L. Foroni's co-authors include Benoît Allenet, Pierrick Bedouch, J. Calop, Carole Schwebel, Claire Chapuis, Jean‐Luc Bosson, Patricia Pavèse, Jean-Philippe Vittoz, Hervé Pelloux and Danièle Maubon and has published in prestigious journals such as Critical Care Medicine, Journal of Antimicrobial Chemotherapy and Critical Care.

In The Last Decade

L. Foroni

25 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Foroni France 13 198 155 152 147 84 28 528
James C. Garrelts United States 14 120 0.6× 124 0.8× 124 0.8× 99 0.7× 41 0.5× 28 579
Rocsanna Namdar United States 10 67 0.3× 169 1.1× 128 0.8× 97 0.7× 20 0.2× 16 513
Khawla Abu Hammour Jordan 15 182 0.9× 45 0.3× 87 0.6× 86 0.6× 153 1.8× 57 543
Carmen Rodríguez Spain 10 91 0.5× 99 0.6× 58 0.4× 82 0.6× 33 0.4× 22 293
Roy Guharoy United States 11 95 0.5× 79 0.5× 45 0.3× 55 0.4× 43 0.5× 36 375
Bertrand Guignard Switzerland 11 221 1.1× 68 0.4× 37 0.2× 66 0.4× 27 0.3× 30 428
Michael Cimino United States 9 102 0.5× 80 0.5× 57 0.4× 126 0.9× 20 0.2× 15 485
Stephen F Eckel United States 16 356 1.8× 28 0.2× 82 0.5× 166 1.1× 100 1.2× 86 798
Evelyn Deasy Ireland 9 125 0.6× 73 0.5× 48 0.3× 79 0.5× 17 0.2× 17 325
María Victoria Gil-Navarro Spain 14 75 0.4× 114 0.7× 160 1.1× 23 0.2× 207 2.5× 46 508

Countries citing papers authored by L. Foroni

Since Specialization
Citations

This map shows the geographic impact of L. Foroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Foroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Foroni more than expected).

Fields of papers citing papers by L. Foroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Foroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Foroni. The network helps show where L. Foroni may publish in the future.

Co-authorship network of co-authors of L. Foroni

This figure shows the co-authorship network connecting the top 25 collaborators of L. Foroni. A scholar is included among the top collaborators of L. Foroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Foroni. L. Foroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bienvenu, Anne‐Lise, Natacha Mrozek, L. Foroni, et al.. (2025). An Overview of Isavuconazole Clinical Use: A Multicentre Analysis of Indications, Exposure and Hepatic Safety. Clinical Drug Investigation. 45(5). 271–282. 1 indexed citations
2.
3.
Hollebeke, Marine Van, Claire Chapuis, L. Foroni, et al.. (2016). Compliance with carbapenem guidelines in a university hospital. Médecine et Maladies Infectieuses. 46(2). 72–78. 4 indexed citations
4.
Bailly, Sébastien, Cécile Garnaud, Muriel Cornet, et al.. (2016). Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia. European Journal of Clinical Microbiology & Infectious Diseases. 35(6). 1023–1032. 7 indexed citations
5.
Bailly, Sébastien, Danièle Maubon, Pierre‐Edouard Fournier, et al.. (2015). Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. – Trends over 10 years. Journal of Infection. 72(1). 103–111. 60 indexed citations
6.
Chapuis, Claire, Pierrick Bedouch, M. Durand, et al.. (2015). Automated drug dispensing systems in the intensive care unit: a financial analysis. Critical Care. 19(1). 318–318. 37 indexed citations
7.
8.
Gibert, P., Jean‐François Timsit, L. Foroni, et al.. (2012). Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units?. Journal of Hospital Infection. 82(4). 293–296. 3 indexed citations
9.
Allenet, Benoît, Pierrick Bedouch, Magalie Baudrant, et al.. (2011). Physicians’ perception of CPOE implementation. International Journal of Clinical Pharmacy. 33(4). 656–664. 9 indexed citations
10.
Bedouch, Pierrick, Magalie Baudrant, José Labarère, et al.. (2011). Computerized physician order entry system combined with on‐ward pharmacist: analysis of pharmacists' interventions. Journal of Evaluation in Clinical Practice. 18(4). 911–918. 51 indexed citations
11.
Fournier, Pierre‐Edouard, Carole Schwebel, Danièle Maubon, et al.. (2011). Antifungal use influences Candida species distribution and susceptibility in the intensive care unit. Journal of Antimicrobial Chemotherapy. 66(12). 2880–2886. 56 indexed citations
12.
Allenet, Benoît, et al.. (2010). DE L'HISTORIQUE MÉDICAMENTEUX À L'OBSERVATION PHARMACEUTIQUE: RECUEIL STANDARDISÉ POUR LE DÉVELOPPEMENT DE LA PHARMACIE CLINIQUE EN UNITÉ DE SOINS. 39–46. 8 indexed citations
13.
Chapuis, Claire, Matthieu Roustit, Carole Schwebel, et al.. (2010). Automated drug dispensing system reduces medication errors in an intensive care setting. Critical Care Medicine. 38(12). 2275–2281. 113 indexed citations
14.
Roustit, Matthieu, Patrice François, Élodie Sellier, et al.. (2009). Evaluation of glycopeptide prescription and therapeutic drug monitoring at a university hospital. Scandinavian Journal of Infectious Diseases. 42(3). 177–184. 18 indexed citations
15.
Pavèse, Patricia, José Labarère, Jean-Philippe Vittoz, et al.. (2009). Does an Educational Session With an Infectious Diseases Physician Reduce the Use of Inappropriate Antibiotic Therapy for Inpatients With Positive Urine Culture Results? A Controlled Before-and-After Study. Infection Control and Hospital Epidemiology. 30(6). 596–599. 38 indexed citations
16.
Bedouch, Pierrick, et al.. (2008). La sécurisation du circuit du médicament dans les établissements de santé : données actuelles et expérience du centre hospitalier universitaire de Grenoble. Annales Pharmaceutiques Françaises. 67(1). 3–15. 28 indexed citations
17.
Pavèse, Patricia, Jean-Philippe Vittoz, B. Lebeau, et al.. (2007). Revue de pertinence des prescriptions des nouveaux antifongiques systémiques dans un hôpital universitaire. Médecine et Maladies Infectieuses. 37. S223–S228. 12 indexed citations
18.
Méan, Marie, Patricia Pavèse, Jean-Philippe Vittoz, et al.. (2006). Prospective assessment of fluoroquinolone use in a teaching hospital. European Journal of Clinical Microbiology & Infectious Diseases. 25(12). 757–763. 16 indexed citations
19.
Pavèse, Patricia, Jean-Philippe Vittoz, L. Foroni, et al.. (2006). Conformité des prescriptions d'antibiotiques dans les infections urinaires de l'adulte en milieu hospitalier. Médecine et Maladies Infectieuses. 36(7). 369–374. 15 indexed citations
20.
Foroni, L., Mallika Sekhar, Thomas J. Butler, et al.. (1994). E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.. PubMed. 8(7). 1131–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James C. Garrelts Breakdown of academic impact, for papers by Rocsanna Namdar Breakdown of academic impact, for papers by Khawla Abu Hammour Breakdown of academic impact, for papers by Carmen Rodríguez Breakdown of academic impact, for papers by Roy Guharoy Breakdown of academic impact, for papers by Bertrand Guignard Breakdown of academic impact, for papers by Michael Cimino Breakdown of academic impact, for papers by Stephen F Eckel Breakdown of academic impact, for papers by Evelyn Deasy Breakdown of academic impact, for papers by María Victoria Gil-Navarro
Rankless by CCL
2026